VU6028418 is a potent, highly selective, and orally active M4 muscarinic acetylcholine receptor (M4 mAChR) antagonist; it is used as a pharmacological tool for studying M4 receptor function and has potential applications in the treatment of neurological and psychiatric disorders involving M4 receptor modulation.